A spike in malaria cases is threatening the health of people in parts of the eastern Democratic Republic of the Congo (DRC) where health workers are also battling an Ebola outbreak. In response, a four-day mass drug administration (MDA) campaign was launched today in the Northern Kivu province town of Beni, with a target to reach up to 450 000 people with anti-malarial drugs combined with the distribution of insecticide-treated mosquito nets.
HIV self-testing presents an opportunity to reach the 30% of people with HIV who do not yet know their HIV status. Following the WHO recommendation to use HIV self-testing as an additional HIV testing tool, more countries are starting to develop and implement policies. As of January 2018, 14 countries were actively implementing HIV self-testing services, 42 had developed policies to enable such services, and an additional 47 reported that a policy was in development.
Democratic Republic of the Congo starts the first-ever multi drug trial for an Ebola treatment. It is part of a multi-outbreak, multi-country study that was agreed to by partners under a WHO initiative.
Entebbe, 26th November 2018:- The Uganda Virus Research Institute (UVRI) has been certified to perform yellow fever regional reference lab functions in the Arbo
The Government of Nigeria – with support from the World Health Organization (WHO), Gavi, the Vaccine Alliance and UNICEF aims to vaccinate 26.2 million people this year through preventive campaigns. The second phase of its biggest-ever yellow fever campaign seeks to establish high population immunity nationwide and began today.
